These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38291227)

  • 1. Identification of VWA5A as a novel biomarker for inhibiting metastasis in breast cancer by machine-learning based protein prioritization.
    Koh J; Jeong D; Park SY; Han D; Kim DS; Kim HY; Kim H; Yang S; Kim S; Ryu HS
    Sci Rep; 2024 Jan; 14(1):2459. PubMed ID: 38291227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome.
    De Palma FDE; Del Monaco V; Pol JG; Kremer M; D'Argenio V; Stoll G; Montanaro D; Uszczyńska-Ratajczak B; Klein CC; Vlasova A; Botti G; D'Aiuto M; Baldi A; Guigó R; Kroemer G; Maiuri MC; Salvatore F
    Pharmacol Res; 2020 Nov; 161():105249. PubMed ID: 33068730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early-stage breast cancer?
    Jones T; Neboori H; Wu H; Yang Q; Haffty BG; Evans S; Higgins S; Moran MS
    Ann Surg Oncol; 2013 Sep; 20(9):2866-72. PubMed ID: 23661183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor status is highly conserved during tumor progression of breast cancer.
    Grogg A; Trippel M; Pfaltz K; Lädrach C; Droeser RA; Cihoric N; Salhia B; Zweifel M; Tapia C
    BMC Cancer; 2015 Nov; 15():872. PubMed ID: 26552477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
    Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
    Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
    Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
    Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer.
    Kulkarni S; Augoff K; Rivera L; McCue B; Khoury T; Groman A; Zhang L; Tian L; Sossey-Alaoui K
    PLoS One; 2012; 7(8):e42895. PubMed ID: 22952619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer.
    Ren X; Song Y; Zhang Y; Wu H; Chen L; Pang J; Zhou L; Shen S; Liang Z
    BMC Cancer; 2022 May; 22(1):548. PubMed ID: 35568835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance and biological function of olfactomedin 4 in triple negative breast cancer.
    Xiong B; Lei X; Zhang L; Fu J
    Biomed Pharmacother; 2017 Feb; 86():67-73. PubMed ID: 27939521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Standardized Evaluation Method for FOXP3+ Tregs and CD8+ T-cells in Breast Carcinoma: Association With Breast Carcinoma Subtypes, Stage and Prognosis.
    Papaioannou E; Sakellakis M; Melachrinou M; Tzoracoleftherakis E; Kalofonos H; Kourea E
    Anticancer Res; 2019 Mar; 39(3):1217-1232. PubMed ID: 30842152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
    Michaelidou K; Ardavanis A; Scorilas A
    Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of distant metastasis in Chinese women according to breast cancer subtypes.
    Wu SG; Sun JY; Yang LC; Tang LY; Wang X; Chen XT; Liu GH; Lin HX; Lin Q; He ZY
    Oncotarget; 2016 Jul; 7(30):47975-47984. PubMed ID: 27322074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How basal are triple-negative breast cancers?
    Bertucci F; Finetti P; Cervera N; Esterni B; Hermitte F; Viens P; Birnbaum D
    Int J Cancer; 2008 Jul; 123(1):236-40. PubMed ID: 18398844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
    Villegas SL; Nekljudova V; Pfarr N; Engel J; Untch M; Schrodi S; Holms F; Ulmer HU; Fasching PA; Weber KE; Albig C; Heinrichs C; Marmé F; Hartmann A; Hanusch C; Schmitt WD; Huober J; Lederer B; van Mackelenbergh M; Tesch H; Jackisch C; Rezai M; Sinn P; Sinn BV; Hackmann J; Kiechle M; Schneeweiss A; Weichert W; Denkert C; Loibl S
    Eur J Cancer; 2021 May; 148():159-170. PubMed ID: 33743484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.
    Elsharawy KA; Althobiti M; Mohammed OJ; Aljohani AI; Toss MS; Green AR; Rakha EA
    Breast Cancer Res Treat; 2021 Feb; 185(3):615-627. PubMed ID: 33161513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.
    Westbrook JA; Wood SL; Cairns DA; McMahon K; Gahlaut R; Thygesen H; Shires M; Roberts S; Marshall H; Oliva MR; Dunning MJ; Hanby AM; Selby PJ; Speirs V; Mavria G; Coleman RE; Brown JE
    J Pathol; 2019 Mar; 247(3):381-391. PubMed ID: 30426503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.
    Imamura T; Yamamoto-Ibusuki M; Sueta A; Kubo T; Irie A; Kikuchi K; Kariu T; Iwase H
    Breast Cancer; 2016 Nov; 23(6):876-885. PubMed ID: 26494574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
    Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression.
    Giannoudis A; Varešlija D; Sharma V; Zakaria R; Platt-Higgins A; Rudland PS; Jenkinson MD; Young LS; Palmieri C
    ESMO Open; 2022 Dec; 7(6):100636. PubMed ID: 36423363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
    Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
    Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.